Speaker illustration

Professor Anetta Undas

Jagiellonian University, Krakow (Poland)

Member of:

European Society of Cardiology

Anetta Undas, MD, PhD, Department of Thromboembolic Diseases, Jagiellonian University Medical College, Kraków, Poland. Main research interests: pathophysiology of thrombosis and atherosclerosis, fibrin, fibrinolysis, thrombophilia, anticoagulation. Main findings: fibrin clot structure and function, especially susceptibility to lytic enzymes, are unfavorably altered in patients with arterial and venous thromboembolic manifestations, both in the acute phase (myocardial infarction, ischemic stroke, venous thrombosis, pulmonary embolism) and importantly, following such events.

The effect of DOAC-Stop on lupus anticoagulant testing in patients with pulmonary embolism receiving direct oral anticoagulants

Event: ESC Congress 2023

Topic: Anticoagulants

Session: Oral anticoagulation in patients with venous thromboembolism or left ventricular thrombus


Reduced fibrin clot permeability is associated with an increased risk of both ischemic stroke and major bleeding in atrial fibrillation patients treated with vitamin k antagonists

Event: ESC Congress 2017

Topic: Atrial fibrillation (AF)

Session: Progress in stroke prevention in atrial fibrillation


Prothrombotic fibrin clot phenotype is associated with recurrent pulmonary embolism following discontinuation of anticoagulant therapy

Event: ESC Congress 2016

Topic: Acute pulmonary embolism

Session: Advances in pulmonary embolism


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb